STOCK TITAN

[Form 4] VolitionRX Limited Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Positive)
Form Type
4
Rhea-AI Filing Summary

On 6 Aug 2025 Concorde International Group Ltd. (NASDAQ: CIGL) furnished a Form 6-K reporting a 17 Jun 2025 press release. The company disclosed that it signed SG$11.621 million (≈US$9.04 million) in new, multi-year recurring-revenue contracts during Jan-May 2025. Wins span both new customers and expanded mandates at existing sites, indicating organic growth and deeper wallet share. No further details—such as contract tenure, expected annual revenue recognition, or margin impact—were provided in the filing excerpt, and Exhibit 99.1 is not included here. The information is furnished, not filed, so it is expressly not subject to Section 18 liability.

Il 6 agosto 2025 Concorde International Group Ltd. (NASDAQ: CIGL) ha fornito un Modulo 6-K riportando un comunicato stampa del 17 giugno 2025. La società ha comunicato di aver firmato contratti ricorrenti pluriennali per un valore di 11,621 milioni di dollari di Singapore (≈9,04 milioni di dollari USA) nel periodo gennaio-maggio 2025. I successi riguardano sia nuovi clienti sia mandati ampliati presso siti esistenti, segnalando una crescita organica e una maggiore quota di portafoglio. Non sono stati forniti ulteriori dettagli — come la durata dei contratti, i ricavi annui previsti o l'impatto sui margini — nell'estratto del documento, e l'Allegato 99.1 non è incluso qui. L'informazione è fornita, ma non depositata, quindi non è soggetta alla responsabilità ai sensi della Sezione 18.

El 6 de agosto de 2025, Concorde International Group Ltd. (NASDAQ: CIGL) presentó un Formulario 6-K que incluye un comunicado de prensa del 17 de junio de 2025. La empresa informó que firmó contratos recurrentes plurianuales por valor de 11,621 millones de dólares de Singapur (≈9,04 millones de dólares estadounidenses) durante enero-mayo de 2025. Los logros abarcan tanto nuevos clientes como mandatos ampliados en sitios existentes, indicando crecimiento orgánico y una mayor participación en la cartera. No se proporcionaron más detalles — como la duración del contrato, los ingresos anuales esperados o el impacto en el margen — en el extracto presentado, y el Anexo 99.1 no está incluido aquí. La información se proporciona, no se presenta formalmente, por lo que expresamente no está sujeta a la responsabilidad bajo la Sección 18.

2025년 8월 6일 Concorde International Group Ltd. (NASDAQ: CIGL)은 2025년 6월 17일 보도자료를 보고하는 Form 6-K를 제출했습니다. 회사는 2025년 1월부터 5월까지 SG$11.621백만(약 미화 9.04백만 달러) 규모의 새로운 다년간 반복 수익 계약을 체결했다고 밝혔습니다. 계약은 신규 고객기존 사이트의 확대된 위임 모두에 걸쳐 있어 유기적 성장과 지갑 점유율 확대를 나타냅니다. 계약 기간, 예상 연간 수익 인식, 마진 영향 등 추가 세부사항은 제출된 발췌문에 포함되어 있지 않으며, 부록 99.1도 여기에 포함되어 있지 않습니다. 이 정보는 제출된 것이 아니라 제공된 것이므로 Section 18 책임 대상이 아닙니다.

Le 6 août 2025, Concorde International Group Ltd. (NASDAQ : CIGL) a fourni un formulaire 6-K rapportant un communiqué de presse du 17 juin 2025. La société a dévoilé avoir signé des contrats récurrents pluriannuels d'un montant de 11,621 millions de dollars de Singapour (≈9,04 millions de dollars US) durant la période de janvier à mai 2025. Ces succès concernent à la fois de nouveaux clients et des mandats élargis sur des sites existants, indiquant une croissance organique et une part de portefeuille plus importante. Aucun détail supplémentaire — comme la durée des contrats, les revenus annuels attendus ou l'impact sur la marge — n’a été fourni dans l’extrait de dépôt, et l’Annexe 99.1 n’est pas incluse ici. L’information est fournie, non déposée, elle n’est donc expressément pas soumise à la responsabilité au titre de la Section 18.

Am 6. August 2025 reichte Concorde International Group Ltd. (NASDAQ: CIGL) ein Formular 6-K ein, das eine Pressemitteilung vom 17. Juni 2025 enthält. Das Unternehmen gab bekannt, dass es im Zeitraum Januar bis Mai 2025 neue, mehrjährige wiederkehrende Umsatzverträge im Wert von 11,621 Millionen SGD (≈9,04 Millionen USD) unterzeichnet hat. Die Erfolge erstrecken sich sowohl auf neue Kunden als auch auf erweiterte Mandate an bestehenden Standorten, was auf organisches Wachstum und einen höheren Anteil am Kundenbudget hinweist. Weitere Details – wie Vertragslaufzeit, erwartete jährliche Umsatzanerkennung oder Margenauswirkungen – wurden im Auszug der Einreichung nicht angegeben, und Anlage 99.1 ist hier nicht enthalten. Die Information wird bereitgestellt, nicht eingereicht, und unterliegt daher ausdrücklich nicht der Haftung gemäß Abschnitt 18.

Positive
  • Secured SG$11.6 million (≈US$9.0 million) in new multi-year recurring revenue contracts, demonstrating both new client acquisition and expansions with existing customers.
Negative
  • Filing provides no specifics on contract length, profitability or percentage of total revenue, limiting assessment of true financial impact.

Insights

TL;DR: US$9 M in new contracts is encouraging, but materiality unclear without baseline revenue; impact judged neutral.

The announcement shows CIGL is adding recurring revenue—strategically positive for visibility and cash-flow quality. However, the filing omits contract duration, margin profile and contribution to backlog. Without knowing prior-year revenue, investors cannot gauge percentage growth. Management’s choice to furnish, rather than file, limits legal weight and detail. I therefore view the news as incrementally positive but not yet a thesis-altering event.

TL;DR: Multi-year wins signal demand resilience; recurring model enhances valuation multiples—moderately positive.

Facilities & engineering players prize long-term, recurring contracts because they smooth revenue volatility. Securing SG$11.6 M across new and existing sites suggests CIGL’s service quality is gaining traction. While size context is missing, such wins often improve customer lifetime value and retention metrics. Assuming execution, the contracts could underpin margin expansion through operating leverage, justifying a positive outlook.

Il 6 agosto 2025 Concorde International Group Ltd. (NASDAQ: CIGL) ha fornito un Modulo 6-K riportando un comunicato stampa del 17 giugno 2025. La società ha comunicato di aver firmato contratti ricorrenti pluriennali per un valore di 11,621 milioni di dollari di Singapore (≈9,04 milioni di dollari USA) nel periodo gennaio-maggio 2025. I successi riguardano sia nuovi clienti sia mandati ampliati presso siti esistenti, segnalando una crescita organica e una maggiore quota di portafoglio. Non sono stati forniti ulteriori dettagli — come la durata dei contratti, i ricavi annui previsti o l'impatto sui margini — nell'estratto del documento, e l'Allegato 99.1 non è incluso qui. L'informazione è fornita, ma non depositata, quindi non è soggetta alla responsabilità ai sensi della Sezione 18.

El 6 de agosto de 2025, Concorde International Group Ltd. (NASDAQ: CIGL) presentó un Formulario 6-K que incluye un comunicado de prensa del 17 de junio de 2025. La empresa informó que firmó contratos recurrentes plurianuales por valor de 11,621 millones de dólares de Singapur (≈9,04 millones de dólares estadounidenses) durante enero-mayo de 2025. Los logros abarcan tanto nuevos clientes como mandatos ampliados en sitios existentes, indicando crecimiento orgánico y una mayor participación en la cartera. No se proporcionaron más detalles — como la duración del contrato, los ingresos anuales esperados o el impacto en el margen — en el extracto presentado, y el Anexo 99.1 no está incluido aquí. La información se proporciona, no se presenta formalmente, por lo que expresamente no está sujeta a la responsabilidad bajo la Sección 18.

2025년 8월 6일 Concorde International Group Ltd. (NASDAQ: CIGL)은 2025년 6월 17일 보도자료를 보고하는 Form 6-K를 제출했습니다. 회사는 2025년 1월부터 5월까지 SG$11.621백만(약 미화 9.04백만 달러) 규모의 새로운 다년간 반복 수익 계약을 체결했다고 밝혔습니다. 계약은 신규 고객기존 사이트의 확대된 위임 모두에 걸쳐 있어 유기적 성장과 지갑 점유율 확대를 나타냅니다. 계약 기간, 예상 연간 수익 인식, 마진 영향 등 추가 세부사항은 제출된 발췌문에 포함되어 있지 않으며, 부록 99.1도 여기에 포함되어 있지 않습니다. 이 정보는 제출된 것이 아니라 제공된 것이므로 Section 18 책임 대상이 아닙니다.

Le 6 août 2025, Concorde International Group Ltd. (NASDAQ : CIGL) a fourni un formulaire 6-K rapportant un communiqué de presse du 17 juin 2025. La société a dévoilé avoir signé des contrats récurrents pluriannuels d'un montant de 11,621 millions de dollars de Singapour (≈9,04 millions de dollars US) durant la période de janvier à mai 2025. Ces succès concernent à la fois de nouveaux clients et des mandats élargis sur des sites existants, indiquant une croissance organique et une part de portefeuille plus importante. Aucun détail supplémentaire — comme la durée des contrats, les revenus annuels attendus ou l'impact sur la marge — n’a été fourni dans l’extrait de dépôt, et l’Annexe 99.1 n’est pas incluse ici. L’information est fournie, non déposée, elle n’est donc expressément pas soumise à la responsabilité au titre de la Section 18.

Am 6. August 2025 reichte Concorde International Group Ltd. (NASDAQ: CIGL) ein Formular 6-K ein, das eine Pressemitteilung vom 17. Juni 2025 enthält. Das Unternehmen gab bekannt, dass es im Zeitraum Januar bis Mai 2025 neue, mehrjährige wiederkehrende Umsatzverträge im Wert von 11,621 Millionen SGD (≈9,04 Millionen USD) unterzeichnet hat. Die Erfolge erstrecken sich sowohl auf neue Kunden als auch auf erweiterte Mandate an bestehenden Standorten, was auf organisches Wachstum und einen höheren Anteil am Kundenbudget hinweist. Weitere Details – wie Vertragslaufzeit, erwartete jährliche Umsatzanerkennung oder Margenauswirkungen – wurden im Auszug der Einreichung nicht angegeben, und Anlage 99.1 ist hier nicht enthalten. Die Information wird bereitgestellt, nicht eingereicht, und unterliegt daher ausdrücklich nicht der Haftung gemäß Abschnitt 18.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Innes Guy Archibald

(Last) (First) (Middle)
1489 WEST WARM SPRINGS ROAD
SUITE 110

(Street)
HENDERSON NV 89014

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
VOLITIONRX LTD [ VNRX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/05/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/05/2025 P 78,125(1) A $0.64 966,814 D
Common Stock 1,400,000 I By The Innes Family Bare Trust 2023(2)
Common Stock 356,000 I By The Dill Faulkes Educational Trust Limited(3)
Common Stock 154,503 I By son
Common Stock 154,503 I By son
Common Stock 154,504 I By daughter
Common Stock 154,504 I By daughter
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Acquired at the offering price in the registered direct offering of Common Stock by VolitionRx.
2. These shares of Common Stock are beneficially owned by The Innes Family Bare Trust 2023, which is a separate legal entity, of which the reporting person is the Trustee, for the benefit of his children.
3. These shares of Common Stock are beneficially owned by The Dill Faulkes Educational Trust Limited ("DFET"), a UK registered charity. The reporting person serves as a director and trustee of DFET and shares voting and dispositive control over these shares but disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
Remarks:
/s/ Guy Archibald Innes 08/06/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Concorde International (CIGL) announce in its August 2025 Form 6-K?

The company reported SG$11.6 million (≈US$9.0 million) in new multi-year recurring revenue contracts signed between January and May 2025.

Are the new contracts from existing or new customers?

According to the filing, the contracts cover both new clients and expanded agreements with existing customers.

Does the 6-K include revenue or earnings guidance?

No. The document only discloses the total contract value and states no additional financial metrics or guidance.

Is the information in Exhibit 99.1 legally filed or just furnished?

It is furnished, not filed, meaning it is not subject to Section 18 liabilities of the Exchange Act.

How large is SG$11.6 million in U.S. dollars?

The company estimates the amount at approximately US$9.04 million.
Volitionrx

NYSE:VNRX

VNRX Rankings

VNRX Latest News

VNRX Latest SEC Filings

VNRX Stock Data

66.55M
83.43M
18.4%
20.49%
0.35%
Medical Devices
In Vitro & in Vivo Diagnostic Substances
Link
United States
HENDERSON